Dr. Douglas Arenberg

98
DocScore

Critical Care , Board Certified

Ann Arbor, MI

Dr. Douglas Arenberg's honors

Dr. Douglas Arenberg's bio

I am a pulmonologist but my practice is exclusively focused on lung cancer, early detection, staging, diagnosis and risk assessment. I work at the University of Michigan with an outstanding team of radiologists, nuclear radiologists, medical & radiation oncologists, surgeons, and pathologists.

Dr. Douglas Arenberg's Locations

  • 1500 E. Medical Center Dr.
  • Ann Arbor MI 48109
  • 734-232-6046
Staticmap?center=1500+e.+medical+center+dr

Dr. Douglas Arenberg's known for

Dr. Douglas Arenberg's Visit Information

APPOINTMENTS

Expert's Gender

  • M

Dr. Douglas Arenberg's SPECIALTIES/AREAS OF PRACTICE & HOSPITAL AFFILIATIONS

Specialties/Practice

  • Iconabms Critical Care
  • Iconabms Pulmonary Critical Care

Dr. Douglas Arenberg's Education & Experience

Academic Appointments

  • Associate Professor of Medicine

Residencies

  • University of Michigan Medical School, MI

Fellowships

Medical Schools

  • University of Illinois College of Medicine, IL 1990

Dr. Douglas Arenberg's Awards & Affiliations

Affiliations

  • International association for the study of lung cancer
  • American Thoracic Society
  • American college of Chest Physicians

Dr. Douglas Arenberg's Publications

Publications

Lung cancer: multidisciplinary approach to tissue sampling.

Radiologic clinics of North America, 2012

Setting up a lung cancer screening program.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Bronchioloalveolar carcinoma.

Seminars in respiratory and critical care medicine, 2011

Diversity of the angiogenic phenotype in non-small cell lung cancer.

American journal of respiratory cell and molecular biology, 2007

Chemokines as therapeutic targets in non-small cell lung cancer.

Current medicinal chemistry. Anti-cancer agents, 2002

Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2003

RANTES expression is a predictor of survival in stage I lung adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002

Dr. Douglas Arenberg's Blog & Additional Links

Posts